CD8 T cell immunity to Plasmodium permits generation of protective antibodies after repeated sporozoite challenge

Vaccine

Volumn 27, Issue 44, 2009, Pages 6103-6106

  Schmidt, Nathan W ^a   Butler, Noah S ^a   Harty, John T ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Antibodies; Memory CD8 T cells; Plasmodium berghei

Indexed keywords

EPITOPE; IMMUNOGLOBULIN G; PROTOZOAL VACCINE; SERYLTYROSYLISOLEUCYLPROLYLSERYLALANYLGLUTAMYLLYSYLISOLEUCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; LISTERIA MONOCYTOGENES; MOUSE; NONHUMAN; PLASMODIUM BERGHEI; PRIORITY JOURNAL; SPOROZOITE;

ADOPTIVE TRANSFER; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CD8-POSITIVE T-LYMPHOCYTES; EPITOPES, T-LYMPHOCYTE; IMMUNOLOGIC MEMORY; MALARIA; MALARIA VACCINES; MICE; MICE, INBRED BALB C; PLASMODIUM BERGHEI; SPOROZOITES;

EID: 70349772921     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.08.025     Document Type: Article

References (17)

1. Greenwood B., and Mutabingwa T. Malaria in 2002. Nature 415 6872 (2002) 670-672
2. Hill A.V. Pre-erythrocytic malaria vaccines: towards greater efficacy. Nat Rev Immunol 6 1 (2006) 21-32
3. Genton B., and Reed Z.H. Asexual blood-stage malaria vaccine development: facing the challenges. Curr Opin Infect Dis 20 5 (2007) 467-475
4. Nussenzweig R.S., Vanderberg J., Most H., and Orton C. Protective immunity produced by the injection of x-irradiated sporozoites of Plasmodium berghei. Nature 216 5111 (1967) 160-162
5. Jobe O., Lumsden J., Mueller A.K., Williams J., Silva-Rivera H., Kappe S.H., et al. Genetically attenuated Plasmodium berghei liver stages induce sterile protracted protection that is mediated by major histocompatibility complex Class I-dependent interferon-gamma-producing CD8+ T cells. J Infect Dis 196 4 (2007) 599-607
6. Tarun A.S., Dumpit R.F., Camargo N., Labaied M., Liu P., Takagi A., et al. Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells. J Infect Dis 196 4 (2007) 608-616
7. Doolan D.L., and Hoffman S.L. The complexity of protective immunity against liver-stage malaria. J Immunol 165 3 (2000) 1453-1462
8. Li S., Rodrigues M., Rodriguez D., Rodriguez J.R., Esteban M., Palese P., et al. Priming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD8+ T-cell-mediated protective immunity against malaria. Proc Natl Acad Sci USA 90 11 (1993) 5214-5218
9. Schneider J., Gilbert S.C., Blanchard T.J., Hanke T., Robson K.J., Hannan C.M., et al. Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara. Nat Med 4 4 (1998) 397-402
10. Anderson R.J., Hannan C.M., Gilbert S.C., Laidlaw S.M., Sheu E.G., Korten S., et al. Enhanced CD8+ T cell immune responses and protection elicited against Plasmodium berghei malaria by prime boost immunization regimens using a novel attenuated fowlpox virus. J Immunol 172 5 (2004) 3094-3100
11. Tao D., Barba-Spaeth G., Rai U., Nussenzweig V., Rice C.M., and Nussenzweig R.S. Yellow fever 17D as a vaccine vector for microbial CTL epitopes: protection in a rodent malaria model. J Exp Med 201 2 (2005) 201-209
12. Tsuji M., and Zavala F. Peptide-based subunit vaccines against pre-erythrocytic stages of malaria parasites. Mol Immunol 38 6 (2001) 433-442
13. Tsuji M., and Zavala F. T cells as mediators of protective immunity against liver stages of Plasmodium. Trends Parasitol 19 2 (2003) 88-93
14. Ophorst O.J., Radosevic K., Havenga M.J., Pau M.G., Holterman L., Berkhout B., et al. Immunogenicity and protection of a recombinant human adenovirus serotype 35-based malaria vaccine against Plasmodium yoelii in mice. Infect Immun 74 1 (2006) 313-320
15. Schmidt N.W., Podyminogin R.L., Butler N.S., Badovinac V.P., Tucker B.J., Bahjat K.S., et al. Memory CD8 T cell responses exceeding a large but definable threshold provide long-term immunity to malaria. Proc Natl Acad Sci USA 105 37 (2008) 14017-14022
16. Schofield L., Villaquiran J., Ferreira A., Schellekens H., Nussenzweig R., and Nussenzweig V. Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites. Nature 330 6149 (1987) 664-666
17. Kumar K.A., Sano G., Boscardin S., Nussenzweig R.S., Nussenzweig M.C., Zavala F., et al. The circumsporozoite protein is an immunodominant protective antigen in irradiated sporozoites. Nature 444 7121 (2006) 937-940